BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04463771-completion@plaintrial.com
DTSTAMP:20261028T033706Z
DTSTART;VALUE=DATE:20260710
SUMMARY:Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combi
 nation With Other Therapies in Participants With Advanced or Metastatic En
 dometrial Cancer Who Have Progressed on or After Platinum-based Chemothera
 py. — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04463771
URL:https://plaintrial.com/trial/NCT04463771
END:VEVENT
END:VCALENDAR